Science must move a reputation slowly. The release process of sound science let alone vaccines and therapies-to develop requires a long timeline. But epidemics of infectious diseases are spreading rapidly, much more demanding faster pace. scientific efforts to better understand the rapid progress SARS-CoV-2, the virus that causes COVID-19, which they did. form within a few weeks after the virus in humans, scientists had already identified and sequenced the genome of the virus, the researchers give a goal to train potential vaccines and treatments. “It ‘s been very, very quickly,” said Dr. Pardis Sabeti, a professor in the Systems Biology Center at Harvard University, at a time 100 the speech, divided into experts and executives how to find hope for the world COVID -19 pandemic. “[Crown] is known to be highly contagious, it is not a moment was to be lost.” Sabeti is a pioneer in the study of infectious diseases as shipped. During the 2014 Ebola outbreak, she and her team helped sequence the Ebola virus behind the data from patients who had been infected. “Once we have the data, which can only be released on the web, and it is assumed that what should be done in an outbreak,” he said. “He broke a lot of obstacles, and we have done a lot of collaborations around the world in the process” Now, many scientists from around the world to share in a similar manner data although online platforms such as Twitter and bioRxiv (pronounced ‘ bio-archive ‘). Knowing what confidence can be difficult. “Part of it is great, and some of it is dangerous because we have a lot of misinformation forever,” he says. have a work permit, but communication tools such as zoom and Slack scientists more than ever, he says. “This is really exciting: the way in which this connection and collaboration that can happen.” Stay up to date on the growing threat to global health, by signing up for our daily newsletter crown. Further progress since the last major Ebola outbreaks-and Zika is that the tools you are asking us now. “The technologies are being pushed at every step,” says Sabeti. “We are producing at the point where we have thousands and thousands of virus genome sequences are very, very quickly.” Create new diagnoses every day. Your team, for example, is using gene therapy to try the CRISPR technology to develop an antiviral therapy and diagnostic tool, covering more than 100 different viruses could run thousands of tests at once to detect. But not all, has not kept pace. Although we had an early start in the decoding of the SARS-CoV-2 genome, “We lost a lot of land we had,” said Sabeti. “Diagnostics only lasted the more the community available to be.” “The next time a new virus comes, we can not take a few months to get to the hospital test,” he said. “The data is available, the technology is available. It has just the process that changes.” The physical, mental and financial depth of the it world. “Infectious diseases kill more people than any modern war, and most of our past wars,” said Sabeti. “We must be able to exchange data in real time in medicine in general, but nowhere more necessary than in infectious diseases place.” This article is part of # TIME100Talks: Finding Hope, a special series with leaders in various fields share their ideas, navigate to the pandemic. I want more? Register for access to multiple virtual events, including live interviews with newsmakers influential. Picture copyright
Related Post
COVID-19 is devastating even nursing homes. The administration Trump does not do much to stop it
At least 75,000 Americans in nursing homes and other structures have long-term care as soon as they died COVID-19 and the devastation is far from...
More than half of Americans fear that the pressure of the White House for a coronavirus vaccine will Rushed
For weeks, the US president Donald Trump has repeatedly forecasts, sometimes bordering on promises that a COVID-19 vaccine is imminent. "We remain on track to...
COVID-19 has killed nearly 200,000 Americans. How many more lives will be lost before the US makes it right?
Forty-five days before the announcement of the first suspected case of what the COVID-19 would be known, the global index of the Health Security has...
Zeneca has taken its COVID-19 vaccine trial after a break for the security check
This story has been updated to reflect AstraZeneca's investigational vaccine shot. AstraZeneca, the British pharmaceutical company behind one of the most promising candidates COVID-19 vaccine...
Nearly 2 million fewer US teens are vaping now than last year, the data show CDC
Nearly 2 million fewer US teens report on e-cigarettes in 2020 compared to 2019, according to new data from the US Centers for Disease Control...
The Great Race Vaccine: The unprecedented rush to immunize the world against COVID-19
The smarter enemies thrive on surprise attacks. Virus and crown in particular are well aware. remain hidden in animal hosts for decades, sometimes mutate constantly,...